TriNet Group Q2 Earnings Call Highlights

TriNet raised its 2026 earnings outlook after improved insurance performance and cost management. Adjusted diluted EPS guidance increased to $4.50–$5.10, while adjusted EBITDA margin guidance rose to 8.5%–9%. Second-quarter revenue fell 5% year over year to $1.2 billion as total worksite employees declined 12% to about 300,000. However, customer attrition improved 36%, and the insurance cost ratio improved to 86%. TriNet is investing in growth through an expanded sales force, broker partnerships, AI-enabled service and health-plan tools, and the integration of its Cocoon leave-management platform.

TriNet Group NYSE: TNET reported second-quarter results that reflected improved insurance performance, stronger customer retention and continued investment in sales and service initiatives, prompting the company to raise its full-year earnings outlook. Total revenue was $1.2 billion, down 5% from a year earlier, primarily reflecting lower worksite employee, or WSE, volumes. The company ended the quarter with about 300,000 total WSEs, down 12% year-over-year but flat sequentially. Co-employed WSEs totaled approximately 274,000, down 11% from the prior-year period.

“At the midpoint of 2026, I’m pleased with the progress we’ve made on our priorities,” President and CEO Mike Simonds said. He cited higher retention, increasing sales momentum, expense management and improved earnings performance. Retention and Pricing Improvements Simonds said TriNet’s health-fee pricing actions over the past 18 months enabled the company to renew customers at rates more closely aligned with market health-cost trends. The company said it saw a combination of improved insurance performance and significantly better customer retention in the second quarter. Overall attrition improved 36% year-over-year. Attrition tied to health-fee pricing declined 58%, while attrition related to service declined 47%, according to Simonds. TriNet is seeking to achieve long-term retention rates several points higher than its historical level of roughly 80%. The company’s second-quarter insurance cost ratio, or ICR, was 86%, improving four percentage points from a year earlier. Chief Financial Officer Mala Murthy said two points of that improvement came from favorable prior-year development, while the other two points resulted from a one-time recovery of insurance administrative costs previously expensed in an earlier decade. Murthy said health-cost trends stabilized in the high single digits during the quarter and were slightly favorable to TriNet’s forecast. The company experienced fewer inpatient procedures than expected and lower-than-forecast pharmaceutical inflation, aided by adoption of biosimilars and stabilization in GLP-1 drug usage. However, she said the company does not view lower pharmaceutical cost inflation as a permanent trend because of the potential introduction of high-cost drugs. TriNet expects its ICR to be higher in the second half than in the first half because of normal seasonal factors, including utilization patterns, deductibles being met and pooling-limit resets.

Sales ended the second quarter flat year-over-year, though Simonds said momentum improved sequentially as customer decision cycles that had lengthened in late March and April began to normalize. He said TriNet expects sales growth in the second half. The company is retaining more experienced sales consultants, with the number of representatives with more than four years of experience rising 7% year-over-year. Productivity among those senior representatives increased 13% during the quarter, and they were, on average, five times more productive than first-year representatives. TriNet’s Ascend sales-development prog...